Lawangsa, Ismael M.

HRN: 07-51-54  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2023
AZITHROMYCIN 500MG TABLET (TAB)
02/03/2023
02/07/2023
PO
500mg
Od
Moderate Pleural Effussion, Right; Cap Mr, Presumptive Ptb,
Waiting Final Action 
02/03/2023
CEFTRIAXONE 1G (VIAL)
02/03/2023
02/09/2023
IVT
2gms
Od
Moderate Pleural Effussion, Right; Cap Mr, Presumptive Ptb,
Waiting Final Action 
02/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/09/2023
02/16/2023
IV
1.5g
Q6
Consolidation Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: